NSTG - NanoString Technologies Inc Stock Price, Fair Value and News

0.20USD+0.03 (+17.65%)Delayed

Market Summary

USD0.20+0.03

Delayed

17.65%

NSTG Stock Price

View Fullscreen

NSTG RSI Chart

NSTG Valuation

Market Cap

9.6M

Price/Earnings (Trailing)

-0.02

Price/Sales (Trailing)

0.02

EV/EBITDA

-0.91

Price/Free Cashflow

-0.03

NSTG Price/Sales (Trailing)

NSTG Profitability

Operating Margin

35.72%

EBT Margin

-102.30%

Return on Equity

-1.2K%

Return on Assets

-60.58%

Free Cashflow Yield

-3.3K%

NSTG Fundamentals

NSTG Revenue

Revenue (TTM)

162.5M

Rev. Growth (Yr)

62.79%

Rev. Growth (Qtr)

8.9%

NSTG Earnings

Earnings (TTM)

-166.4M

Earnings Growth (Yr)

-1.97%

Earnings Growth (Qtr)

14.33%

Breaking Down NSTG Revenue

Last 7 days

-11.1%

Last 30 days

-50%

Last 90 days

-80%

Trailing 12 Months

-99.2%

How does NSTG drawdown profile look like?

NSTG Financial Health

Current Ratio

2.73

Debt/Equity

16.72

Debt/Cashflow

-0.5

NSTG Investor Care

Shares Dilution (1Y)

3.15%

Diluted EPS (TTM)

-3.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	132.0M	143.9M	162.5M	0
2022	144.5M	142.9M	135.3M	127.3M
2021	122.3M	133.6M	138.9M	145.1M
2020	124.5M	116.7M	118.0M	117.3M
2019	111.3M	116.7M	118.7M	125.6M
2018	119.9M	110.3M	111.9M	106.7M
2017	89.9M	101.8M	104.9M	114.9M
2016	65.8M	75.3M	83.6M	86.5M
2015	50.4M	52.6M	56.0M	62.7M
2014	34.5M	38.1M	42.1M	47.6M
2013	24.1M	25.4M	27.8M	31.4M
2012	19.1M	20.4M	21.7M	23.0M
2011	0	0	0	17.8M
2010	0	0	0	11.7M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of NanoString Technologies Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 18, 2024	foy teresa m.	acquired	-	-	3,841	-
Mar 08, 2024	rollison dana e.	acquired	-	-	1,676	-
Mar 08, 2024	george janet	acquired	-	-	1,676	-
Mar 05, 2024	beechem joseph m	acquired	-	-	46,073	svp, research & development
Mar 05, 2024	bailey k thomas	acquired	-	-	46,073	chief financial officer
Mar 05, 2024	gray r bradley	acquired	-	-	152,565	president and ceo
Sep 01, 2023	beechem joseph m	acquired	1,234	2.189	564	svp, research & development
Sep 01, 2023	gray r bradley	acquired	628	2.189	287	president and ceo
Jun 17, 2023	malloy kirk	acquired	-	-	14,851	-
Jun 17, 2023	finney elisha w	acquired	-	-	14,851	-

Which funds bought or sold NSTG recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 16, 2024	Cedar Mountain Advisors, LLC	sold off	-100	-154	-	-%
Apr 15, 2024	THOMPSON INVESTMENT MANAGEMENT, INC.	unchanged	-	-1,069	128	-%
Apr 11, 2024	Ballentine Partners, LLC	sold off	-100	-28,552	-	-%
Apr 10, 2024	Green Alpha Advisors, LLC	sold off	-100	-66,170	-	-%
Apr 05, 2024	LOS ANGELES CAPITAL MANAGEMENT LLC	sold off	-100	-427,351	-	-%
Mar 28, 2024	Newbridge Financial Services Group, Inc.	unchanged	-	-263	203	-%
Mar 11, 2024	VANGUARD GROUP INC	added	6.16	-3,303,950	2,836,200	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	124	-29,237	1,185,260	-%
Feb 28, 2024	AMERICAN INTERNATIONAL GROUP, INC.	reduced	-0.4	-23,000	17,592	-%
Feb 26, 2024	Virtu Financial LLC	new	-	60,000	60,000	-%

Are Funds Buying or Selling NSTG?

Are funds buying NSTG calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NSTG

No. of Funds

Unveiling NanoString Technologies Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 07, 2024	blackrock inc.	0.3%	164,574	SC 13G/A
Feb 14, 2024	barclays plc	7.09%	3,411,407	SC 13G
Feb 14, 2024	pura vida investments, llc	0.00%	0	SC 13G/A
Feb 14, 2024	ra capital management, l.p.	0%	0	SC 13G/A
Feb 13, 2024	prosight management, lp	0.0%	0	SC 13G/A
Feb 13, 2024	polar capital holdings plc	8.26%	3,975,000	SC 13G/A
Feb 13, 2024	avidity partners management lp	0%	0	SC 13G/A
Feb 13, 2024	vanguard group inc	7.88%	3,789,691	SC 13G/A
Feb 12, 2024	platinum investment management ltd	-	0	SC 13G
Jan 26, 2024	blackrock inc.	7.4%	3,574,938	SC 13G/A

Recent SEC filings of NanoString Technologies Inc

View All Filings

Date Filed	Form Type	Document
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	8-K	Current Report
Apr 09, 2024	25-NSE	25-NSE
Mar 22, 2024	8-K	Current Report
Mar 15, 2024	NT 10-K	NT 10-K
Mar 12, 2024	8-K	Current Report
Mar 11, 2024	4	Insider Trading
Mar 11, 2024	4	Insider Trading
Mar 07, 2024	4	Insider Trading
Mar 07, 2024	4	Insider Trading

Peers (Alternatives to NanoString Technologies Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.2B	40.1B	-3.77%	-2.76%	32.53	4.64	-8.12%	-17.45%
BDX	67.7B	19.5B	-1.53%	-10.57%	53.87	3.47	4.02%	-22.04%
ALGN	22.5B	3.9B	-9.16%	-15.16%	50.45	5.81	3.42%	23.09%
BAX	20.0B	14.8B	-5.62%	-8.72%	7.55	1.35	2.12%	209.17%
MID-CAP
ATR	9.2B	3.5B	-0.49%	17.01%	32.33	2.64	4.97%	18.89%
HSIC	9.1B	12.3B	-5.22%	-14.61%	21.9	0.74	-2.44%	-22.68%
BIO	8.2B	2.7B	-16.90%	-39.13%	-12.81	3.06	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.41%	-25.34%	-47.02	1.6	1.10%	85.84%
AXNX	3.4B	366.4M	-2.66%	12.41%	-562.64	9.32	33.86%	89.83%
PDCO	2.3B	6.6B	-4.93%	-3.92%	12.05	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.2B	3.2B	-14.38%	-20.49%	-1.83	0.39	7.73%	-1066.14%
ANIK	383.7M	166.7M	0.86%	-5.21%	-4.64	2.3	6.67%	-456.34%
ANGO	250.7M	324.0M	11.81%	-29.38%	-1.3	0.77	-3.19%	-337.41%
APYX	45.7M	52.3M	-28.65%	-55.25%	-2.44	0.87	17.61%	19.28%
AEMD	3.8M	3.7M	-10.98%	147.46%	-0.31	1.02	5.77%	8.23%

NanoString Technologies Inc News

Latest updates

NanoString Technologies Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	8.9%	48,089,000	44,157,000	35,805,000	34,422,000	29,541,000	32,219,000	31,080,000	42,455,000	37,150,000	33,863,000	31,617,000	36,262,000	31,845,000	22,604,000	26,605,000	36,931,000	30,604,000	30,345,000	27,688,000	30,032,000	28,616,000
Cost Of Revenue	3.1%	30,686,000	29,757,000	22,871,000	21,122,000	13,723,000	15,852,000	14,778,000	20,046,000	17,154,000	15,481,000	15,623,000	16,718,000	13,962,000	10,712,000	11,017,000	14,800,000	10,925,000	9,605,000	8,709,000	10,793,000	9,291,000
Costs and Expenses	-2.9%	84,556,000	87,047,000	76,355,000	77,103,000	64,482,000	69,310,000	68,550,000	69,804,000	66,524,000	59,498,000	57,485,000	55,331,000	49,429,000	46,363,000	54,240,000	59,650,000	51,314,000	49,133,000	48,172,000	47,622,500	43,752,000
S&GA Expenses	-5.9%	36,755,000	39,076,000	37,366,000	36,895,000	33,767,000	36,112,000	36,355,000	31,596,000	30,253,000	26,855,000	26,799,000	23,990,000	20,474,000	19,912,000	25,721,000	26,878,000	23,382,000	22,499,000	23,436,000	20,298,500	17,810,000
R&D Expenses	-6.0%	17,115,000	18,214,000	16,118,000	19,086,000	16,992,000	17,346,000	17,417,000	18,162,000	19,117,000	17,162,000	15,063,000	14,623,000	14,993,000	15,739,000	17,502,000	17,972,000	17,007,000	17,029,000	16,027,000	16,531,000	16,651,000
EBITDA Margin	8.7%	-0.93	-1.02	-1.10	-1.14	-0.97	-0.88	-0.79	-0.71	-0.71	-0.66	-0.72	-0.85	-	-	-	-	-	-	-	-	-
Income Taxes	-123.9%	-49,000	205,000	75,000	-5,000	57,000	184,000	81,000	84,000	-59,000	82,000	60,000	53,000	71,000	69,000	60,000	58,000	64,000	68,000	79,000	64,000	57,000
Earnings Before Taxes	13.8%	-37,460,000	-43,463,000	-41,163,000	-44,119,000	-36,633,000	-39,055,000	-39,419,000	-29,177,000	-31,320,000	-26,938,000	-27,652,000	-22,951,000	-21,246,000	-27,064,000	-38,564,000	24,045,000	-22,684,000	-19,969,000	-21,819,000	-21,046,500	-16,429,000
EBT Margin	11.0%	-1.02	-1.15	-1.22	-1.25	-1.07	-0.97	-0.88	-0.79	-0.78	-0.74	-0.81	-0.94	-	-	-	-	-	-	-	-	-
Net Income	14.3%	-37,411,000	-43,668,000	-41,238,000	-44,114,000	-36,690,000	-39,239,000	-39,500,000	-29,261,000	-31,261,000	-27,020,000	-27,712,000	-23,004,000	-21,317,000	-27,133,000	-38,624,000	23,987,000	-22,748,000	-20,037,000	-21,898,000	-21,111,000	-16,486,000
Net Income Margin	11.0%	-1.02	-1.15	-1.22	-1.25	-1.07	-0.97	-0.88	-0.79	-0.78	-0.74	-0.81	-0.94	-	-	-	-	-	-	-	-	-
Free Cashflow	46.0%	-19,511,000	-36,131,000	-40,731,000	-30,948,000	-41,664,000	-37,103,000	-33,255,000	-19,163,000	-29,783,000	-16,423,000	-31,528,000	-11,529,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-4.9%	275	289	320	353	384	413	445	479	493	513	521	544	333	347	365	260	221	233	221	148	151
Current Assets	-4.4%	212	221	252	287	319	355	387	428	446	466	474	499	287	300	317	213	178	190	182	132	136
Cash Equivalents	-17.9%	94.00	114	121	112	117	126	98.00	107	107	160	397	412	171	168	156	29.00	23.00	33.00	84.00	24.00	21.00
Inventory	12.9%	55.00	49.00	47.00	43.00	46.00	42.00	35.00	31.00	31.00	29.00	24.00	23.00	26.00	26.00	22.00	20.00	19.00	16.00	13.00	13.00	15.00
Net PPE	-6.1%	45.00	48.00	48.00	44.00	40.00	35.00	33.00	27.00	21.00	22.00	22.00	21.00	21.00	21.00	21.00	20.00	15.00	15.00	14.00	15.00	15.00
Liabilities	4.8%	325	310	307	308	301	301	299	303	294	293	284	237	230	232	230	156	148	147	126	111	99.00
Current Liabilities	24.2%	78.00	62.00	58.00	59.00	51.00	52.00	50.00	52.00	44.00	43.00	34.00	37.00	32.00	35.00	35.00	45.00	38.00	37.00	38.00	43.00	37.00
Long Term Debt	0.2%	228	227	227	227	226	226	226	225	225	224	224	173	170	167	165	80.00	79.00	78.00	59.00	58.00	50.00
Shareholder's Equity	-	-	-	14.00	46.00	83.00	113	145	177	199	220	236	307	103	115	135	104	73.00	86.00	95.00	37.00	52.00
Retained Earnings	-4.2%	-931	-894	-850	-809	-765	-728	-689	-649	-620	-589	-562	-542	-519	-497	-470	-431	-455	-433	-413	-391	-370
Additional Paid-In Capital	1.0%	881	873	864	856	849	843	836	827	820	809	799	849	621	612	606	536	528	519	508	428	422
Shares Outstanding	1.2%	48.00	48.00	47.00	47.00	47.00	46.00	46.00	46.00	45.00	45.00	45.00	39.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	-	-	-	-	-	-	-	-	586	-	-	-	1,100	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	37.4%	-19,699	-31,448	-35,749	-28,081	-37,802	-32,470	-30,253	-17,519	-28,863	-15,311	-28,856	-10,880	-20,643	-22,356	-27,783	-19,536	-20,729	-20,979	-28,177	-14,415	-11,327
Share Based Compensation	-11.8%	7,440	8,436	7,626	6,264	5,519	6,458	7,667	6,484	8,284	7,989	7,416	6,297	4,983	3,791	4,303	4,752	4,748	5,076	2,882	2,792	2,835
Cashflow From Investing	-107.9%	-1,916	24,308	43,798	24,113	27,713	59,966	20,705	16,608	-26,547	-222,973	12,690	29,851	19,057	32,492	9,841	22,187	6,260	-54,861	11,255	2,570	-48,773
Cashflow From Financing	2183.3%	822	36.00	814	-53.00	1,210	155	960	839	2,228	2,135	856	221,304	4,498	2,672	144,574	2,895	4,587	25,099	76,685	14,987	57,018

NSTG Income Statement

2023-09-30

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue:
Revenue	$ 48,089	$ 29,541	$ 128,051	$ 92,840
Costs and expenses:
Cost of product revenue	30,686	13,723	83,314	44,353
Research and development	17,115	16,992	51,447	51,755
Selling, general and administrative	36,755	33,767	113,197	106,234
Total costs and expenses	84,556	64,482	247,958	202,342
Loss from operations	(36,467)	(34,941)	(119,907)	(109,502)
Other income (expense):
Interest income	1,355	774	4,167	1,331
Interest expense	(1,897)	(1,887)	(5,677)	(5,650)
Other expense, net	(451)	(579)	(669)	(1,286)
Total other expense, net	(993)	(1,692)	(2,179)	(5,605)
Net loss before provision for income tax	(37,460)	(36,633)	(122,086)	(115,107)
Benefit (provision) for income tax	49	(57)	(231)	(322)
Net loss	$ (37,411)	$ (36,690)	$ (122,317)	$ (115,429)
Net loss per share - basic (in dollars per share)	$ (0.78)	$ (0.79)	$ (2.58)	$ (2.49)
Net loss per share - diluted (in dollars per share)	$ (0.78)	$ (0.79)	$ (2.58)	$ (2.49)
Weighted average shares used in computing basic net loss per share (in shares)	47,715	46,529	47,341	46,320
Weighted average shares used in computing diluted net loss per share (in shares)	47,715	46,529	47,341	46,320
Product
Revenue:
Revenue	$ 41,905	$ 24,605	$ 111,937	$ 78,561
Costs and expenses:
Cost of product revenue	25,668	10,159	68,363	33,592
Service and other revenue
Revenue:
Revenue	6,184	4,936	16,114	14,279
Costs and expenses:
Cost of product revenue	$ 5,018	$ 3,564	$ 14,951	$ 10,761

NSTG Balance Sheet

2023-09-30

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 93,802	$ 112,250
Restricted cash and cash equivalents	296	898
Short-term investments	3,299	84,282
Accounts receivable, net	48,352	31,506
Inventory, net	55,159	43,273
Prepaid expenses and other	10,899	14,565
Total current assets	211,807	286,774
Property and equipment, net	44,991	44,457
Operating lease right-of-use assets	14,420	17,581
Other assets	3,495	4,600
Total assets	274,713	353,412
Current liabilities:
Accounts payable	33,335	16,619
Accrued liabilities	9,573	7,884
Accrued compensation and other employee benefits	14,545	17,494
Customer deposits	1,653	1,757
Deferred revenue, current portion	12,848	9,588
Operating lease liabilities, current portion	5,578	5,518
Total current liabilities	77,532	58,860
Deferred revenue, net of current portion	5,623	3,754
Long-term debt, net	227,764	226,622
Operating lease liabilities, net of current portion	14,360	18,362
Total liabilities	325,279	307,598
Commitment and contingencies (Note 10)
Stockholders’ equity (deficit):
Preferred stock, $0.0001 par value, 15,000 shares authorized; none issued	0	0
Common stock, $0.0001 par value, 150,000 shares authorized; 48,108 and 46,719 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	5	5
Additional paid-in capital	881,038	855,694
Accumulated other comprehensive loss (income)	4	(589)
Accumulated deficit	(931,613)	(809,296)
Total stockholders’ equity (deficit)	(50,566)	45,814
Total liabilities and stockholders’ equity (deficit)	$ 274,713	$ 353,412

About NanoString Technologies Inc

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

CEO	Mr. R. Bradley Gray
WEBSITE	nanostring.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	703

NanoString Technologies Inc Frequently Asked Questions

What is the ticker symbol for NanoString Technologies Inc? What does NSTG stand for in stocks?

NSTG is the stock ticker symbol of NanoString Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NanoString Technologies Inc (NSTG)?

As of Fri Apr 19 2024, market cap of NanoString Technologies Inc is 9.62 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NSTG stock?

You can check NSTG's fair value in chart for subscribers.

What is the fair value of NSTG stock?

You can check NSTG's fair value in chart for subscribers. The fair value of NanoString Technologies Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of NanoString Technologies Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NSTG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is NanoString Technologies Inc a good stock to buy?

The fair value guage provides a quick view whether NSTG is over valued or under valued. Whether NanoString Technologies Inc is cheap or expensive depends on the assumptions which impact NanoString Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NSTG.

What is NanoString Technologies Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, NSTG's PE ratio (Price to Earnings) is -0.02 and Price to Sales (PS) ratio is 0.02. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NSTG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on NanoString Technologies Inc's stock?

In the past 10 years, NanoString Technologies Inc has provided -0.41 (multiply by 100 for percentage) rate of return.